These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
512 related articles for article (PubMed ID: 28103901)
1. Pathogenic LRRK2 variants are gain-of-function mutations that enhance LRRK2-mediated repression of β-catenin signaling. Berwick DC; Javaheri B; Wetzel A; Hopkinson M; Nixon-Abell J; Grannò S; Pitsillides AA; Harvey K Mol Neurodegener; 2017 Jan; 12(1):9. PubMed ID: 28103901 [TBL] [Abstract][Full Text] [Related]
2. A proteomic analysis of LRRK2 binding partners reveals interactions with multiple signaling components of the WNT/PCP pathway. Salašová A; Yokota C; Potěšil D; Zdráhal Z; Bryja V; Arenas E Mol Neurodegener; 2017 Jul; 12(1):54. PubMed ID: 28697798 [TBL] [Abstract][Full Text] [Related]
3. Dysregulated Wnt and NFAT signaling in a Parkinson's disease LRRK2 G2019S knock-in model. Wetzel A; Lei SH; Liu T; Hughes MP; Peng Y; McKay T; Waddington SN; Grannò S; Rahim AA; Harvey K Sci Rep; 2024 May; 14(1):12393. PubMed ID: 38811759 [TBL] [Abstract][Full Text] [Related]
4. High lithium levels in tobacco may account for reduced incidences of both Parkinson's disease and melanoma in smokers through enhanced β-catenin-mediated activity. Guttuso T Med Hypotheses; 2019 Oct; 131():109302. PubMed ID: 31443765 [TBL] [Abstract][Full Text] [Related]
5. The role of LRRK2 in cell signalling. Harvey K; Outeiro TF Biochem Soc Trans; 2019 Feb; 47(1):197-207. PubMed ID: 30578345 [TBL] [Abstract][Full Text] [Related]
6. Lrrk2 modulation of Wnt signaling during zebrafish development. Wint JM; Sirotkin HI J Neurosci Res; 2020 Oct; 98(10):1831-1842. PubMed ID: 32623786 [TBL] [Abstract][Full Text] [Related]
7. Identification of Targets from LRRK2 Rescue Phenotypes. Toh J; Chua LL; Ho P; Sandanaraj E; Tang C; Wang H; Tan EK Cells; 2021 Jan; 10(1):. PubMed ID: 33466414 [TBL] [Abstract][Full Text] [Related]
8. The Parkinson's disease VPS35[D620N] mutation enhances LRRK2-mediated Rab protein phosphorylation in mouse and human. Mir R; Tonelli F; Lis P; Macartney T; Polinski NK; Martinez TN; Chou MY; Howden AJM; König T; Hotzy C; Milenkovic I; Brücke T; Zimprich A; Sammler E; Alessi DR Biochem J; 2018 Jun; 475(11):1861-1883. PubMed ID: 29743203 [TBL] [Abstract][Full Text] [Related]
9. Parkinson's Disease-Associated LRRK2 Hyperactive Kinase Mutant Disrupts Synaptic Vesicle Trafficking in Ventral Midbrain Neurons. Pan PY; Li X; Wang J; Powell J; Wang Q; Zhang Y; Chen Z; Wicinski B; Hof P; Ryan TA; Yue Z J Neurosci; 2017 Nov; 37(47):11366-11376. PubMed ID: 29054882 [TBL] [Abstract][Full Text] [Related]
10. Dopaminergic neurodegeneration induced by Parkinson's disease-linked G2019S LRRK2 is dependent on kinase and GTPase activity. Nguyen APT; Tsika E; Kelly K; Levine N; Chen X; West AB; Boularand S; Barneoud P; Moore DJ Proc Natl Acad Sci U S A; 2020 Jul; 117(29):17296-17307. PubMed ID: 32631998 [TBL] [Abstract][Full Text] [Related]
11. LRRK2 functions as a Wnt signaling scaffold, bridging cytosolic proteins and membrane-localized LRP6. Berwick DC; Harvey K Hum Mol Genet; 2012 Nov; 21(22):4966-79. PubMed ID: 22899650 [TBL] [Abstract][Full Text] [Related]
12. L'RRK de Triomphe: a solution for LRRK2 GTPase activity? Nixon-Abell J; Berwick DC; Harvey K Biochem Soc Trans; 2016 Dec; 44(6):1625-1634. PubMed ID: 27913671 [TBL] [Abstract][Full Text] [Related]
13. Mutations in the LRRK2 Roc-COR tandem domain link Parkinson's disease to Wnt signalling pathways. Sancho RM; Law BM; Harvey K Hum Mol Genet; 2009 Oct; 18(20):3955-68. PubMed ID: 19625296 [TBL] [Abstract][Full Text] [Related]
14. LRRK2 maintains mitochondrial homeostasis and regulates innate immune responses to Weindel CG; Bell SL; Vail KJ; West KO; Patrick KL; Watson RO Elife; 2020 Feb; 9():. PubMed ID: 32057291 [TBL] [Abstract][Full Text] [Related]